1/34
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Indications/warnings
Procardia (nifedipine) - DCCB
Norvasc (amlodipine) - DCCB
hypertension
hypotension risk
Side effects
Procardia (nifedipine) - DCCB
Norvasc (amlodipine) - DCCB
well tolerated; peripheral edema, gingival hyperplasia, HA, flushing, palpitations, reflex tachycardia
Notes
Procardia (nifedipine) - DCCB
ER formulation for pregnant
Notes
Norvasc (amlodipine) - DCCB
Safest CCB to use to lower BP in HFrEF if CCB necessary
Indications / Contra
Cardizem, Tiazac (dilitazem) - NDCCB
Calan (Verapamil) - NDCCB
arrhythmias, hypertension
HF w/ reduced ejection fraction (HFrEF), severe hypotension (SBP < 90mmHG), 2nd/3rd degree heart block
Warnings / side effects
Cardizem, Tiazac (dilitazem) - NDCCB
Calan (Verapamil) - NDCCB
HF symptoms may worse, hypotension
Edema, constipation (inc w/ verapamil), gingival hyperplasia
indications / warnings / side effects
Intuniv (guanfacine) - alpha 2 adrenergic agonist
Hypertension, ADHD
dont d/c abruptly (rebound HBP)
dry mouth, somnolence, fatigue, dizzy, constipation, dec HR, hypotension
Indications / Contra / Side effects
Coumadin, Jantoven (Warfarin) - Vitamin K antagonist; anticoagulant
strove prevention in atrial fibrillation, VTE prophylaxis/treatment
pregnant (hazardous)
bruising/bleeding, skin necrosis, purple toe syndrom
BBW / warnings
Coumadin, Jantoven (Warfarin) - Vitamin K antagonist; anticoagulant
major/fatal bleeding
tissue necrosis/gangrene, CYP2C9*2 /*3 alleles or polymorphism of VKORC1 gene (inc risk of bleeding)
Drug interactions / counseling
Coumadin, Jantoven (Warfarin) - Vitamin K antagonist; anticoagulant
warfarin is CYP2C9 substrate - lots of interactions
CYP2C9 inducers dec INR (phenobarbital, carbamazepine), CYP2C9 inc INR (amiodarone, fluconazole, metronidazole)
Indications / Contra
Ecotrin (aspirin) - antiplatelet, salicylate, NSAID
2ndary stroke prevention, stable ischemic heart disease
NSAID or salicylate allergy, below 18 (risk of reyes syndrome)
Side effects / warning / drug interactions
Ecotrin (aspirin) - antiplatelet, salicylate, NSAID
dyspepsia, heartburn, bleeding
bleeding
monitor w/ other drugs that inc bleeding risk (NSAIDs, antiplatelets)
Indications / contra
Brilinta (ticagrelor) - P2Y12 antagonist; antiplatelet
acute coronary syndrome
active serious bleeding
BBW / side effects / drug interactions
Brilinta (ticagrelor) - P2Y12 antagonist; antiplatelet
significant bleeding risk
bleeding, dyspnea
monitor w. other drugs that inc bleeding risk
indications / contra
Pradaxa (dabigatran etexilate) - Direct Thrombin Inhibitor, DOAC
stroke prevention in atrial fibrillation, VTE treatment
active bleeding, mechanical prosthetic heart valves
BBW / drug interactions
Pradaxa (dabigatran etexilate) - Direct Thrombin Inhibitor, DOAC
neurazial anesthesia or spinal puncture (risk of hematoma & paralysis)
monitor w/ drugs that inc bleeding risk
Side effects / counseling
Pradaxa (dabigatran etexilate) - Direct Thrombin Inhibitor, DOAC
Dyspepsia, gastritis like symptoms, bleeding (esp. GI)
keep in OG container, swallow Capsules whole
BBW / side effects
Xarelto (rivaroxaban) - Factor Xa inhibitor, DOAC
Eliquis (apixaban) - Factor Xa inhibitor, DOAC
neurazial anesthesia or spinal puncture (risk of hematoma & paralysis)
well tolerated; bleeding risk
Contra / drug interactions
Xarelto (rivaroxaban) - Factor Xa inhibitor, DOAC
Eliquis (apixaban) - Factor Xa inhibitor, DOAC
active bleeding
bleeding risk drugs
indications / counseling
Xarelto (rivaroxaban) - Factor Xa inhibitor, DOAC
stroke prevention in atrial fibrillation, VTE prophylaxis/treatment
doses > 15mg tk w/ food; d/c 24 hr before elective surgery
indications /Counseling
Eliquis (apixaban) - Factor Xa inhibitor, DOAC
stroke prevention in atrial fibrillation, VTE prophylaxis/treatment, DVT prophylaxis after knee/hip replacement
d/c 24 hr before elective surgery w/ low bleed risk or 48 hr before w/ med-high bleed risk
indications / contra
Plavix (clopidogrel) - P2Y12 antagonist, antiplatelet
2ndary stroke prevention, stable ischemic heart disease
active serious bleeding
BBW / warning
Plavix (clopidogrel) - P2Y12 antagonist, antiplatelet
CYP2C19 poor metabolizers inc risk cv events bc drug → active metabolite by CYP2C19.
bleeding risk
Side effects / drug interactions
Plavix (clopidogrel) - P2Y12 antagonist, antiplatelet
well tolerated; bleeding risk
drugs inc bleeding risk; no omeprazole or esomeprazole (CYP2C19 inhibitors dec effect)
indications / contra
Lovenox (enoxaparin) - LWMH
VTE prophylaxis/treatment
history of HIT, active major bleed
BBW / drug interactions
Lovenox (enoxaparin) - LWMH
neuraxial anesthesia or spinal puncture (risk of hematoma and paralysis)
drugs with inc bleeding risk
side effects / notes
Lovenox (enoxaparin) - LWMH
bleeding, anemia, injection site brusing/pain, thrombocytopenia
prefilled syringe for subq inj; dont expel air bubbles b4 inj
Indications / warnings
Apresoline (hydralazine) - vasodilator, antiHBP
Hypertension, HF
drug induced lupus erthematosus (DILE)
side effects / notes
Apresoline (hydralazine) - vasodilator, antiHBP
peipheral edmea, HA, flushing, palpitations, reflex tachycardia
used to dec BP in HF pt who cant take ACE/ARB’s
Indications / contra
Imdur (isosorbide mononitrate) - Nitroglycerin antianginal, vasodilator
Nitrostat (nitroglycerin SL) - Nitroglycerin antianginal, vasodilator
angina
NOT w/ PDE5 inhibitors (w/in 24 hr sildenafil or 48 hr tadalafil )
warning / side effect
Imdur (isosorbide mononitrate) - Nitroglycerin antianginal, vasodilator
Nitrostat (nitroglycerin SL) - Nitroglycerin antianginal, vasodilator
hypotension, HA, tachyphylaxis
HA, flushing, syncope
notes
Imdur (isosorbide mononitrate) - Nitroglycerin antianginal, vasodilator
IR - dosed BID 7 hr apart to allow for a nitrate-free interval (dec risk of tolerance)
Counseling
Nitrostat (nitroglycerin SL) - Nitroglycerin antianginal, vasodilator
OG container at room temp; SL let dissolve, call 911 if pain cont after 1st dose; max 3 doses in 15 mins (5 min apart)
Indications / contra
Ranexa (ranolazine) - antianginal, CV agent
angina
Strong CYP3A4 inhibitor or inducer
Warning / Side effect / Notes
Ranexa (ranolazine) - antianginal, CV agent
QT prolongation
dizzy, HA
not for acute treatment of angina